Compare WMS & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WMS | KRYS |
|---|---|---|
| Founded | 1966 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 9.6B |
| IPO Year | 2014 | 2017 |
| Metric | WMS | KRYS |
|---|---|---|
| Price | $127.40 | $327.51 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 12 |
| Target Price | $182.25 | ★ $392.11 |
| AVG Volume (30 Days) | ★ 659.8K | 204.3K |
| Earning Date | 11-05-2026 | 11-02-2026 |
| Dividend Yield | ★ 0.63% | N/A |
| EPS Growth | N/A | ★ 128.00 |
| EPS | 2.19 | ★ 3.62 |
| Revenue | ★ $3,050,376,000.00 | $389,130,000.00 |
| Revenue This Year | $13.32 | $31.33 |
| Revenue Next Year | $6.24 | $27.55 |
| P/E Ratio | ★ $59.82 | $93.08 |
| Revenue Growth | 5.03 | ★ 33.94 |
| 52 Week Low | $124.75 | $179.16 |
| 52 Week High | $179.32 | $382.54 |
| Indicator | WMS | KRYS |
|---|---|---|
| Relative Strength Index (RSI) | 39.51 | 41.98 |
| Support Level | N/A | $331.79 |
| Resistance Level | $155.37 | $371.16 |
| Average True Range (ATR) | 3.35 | 9.85 |
| MACD | 0.37 | -1.37 |
| Stochastic Oscillator | 15.07 | 17.44 |
Advanced Drainage Systems Inc designs, manufactures and markets water management solutions in the stormwater and onsite wastewater industries, providing superior drainage solutions for use in the construction and agriculture markets. The company's products are used across a broad range of end markets and applications, including non-residential, residential, infrastructure and agriculture applications. It has two reportable segments: Stormwater and Wastewater. It derives the majority of revenue from the Stormwater segment, which manufactures and markets thermoplastic corrugated pipe and complementary products, including single wall pipe, N-12 HDPE pipe, polypropylene pipe, StormTech, Nyloplast, Inserta Tee, water quality filters and structures, and NDS channel drains, and access boxes.
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.